NebivololA Review of its Use in the Management of Hypertension and Chronic Heart Failure

[1] McNeely W(1999)Nebivolol in the management of essential hypertension: a review Drugs 57 633-51

[2] Goa KL(2005)Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis Lancet 366 1545-53

[3] Lindholm LH(2004)Atenolol in hypertension: is it a wise choice? Lancet 364 1684-9

[4] Carlberg B(2004)Expert consensus document on β-adrenergic receptor blockers The task force on beta-blockers of the European Society of Cardiology. Eur Heart J 25 1341-62

[5] Samuelsson O(1992)Pharmacology of nebivolol J Pharm Belg 47 323-7

[6] Carlberg B(2004)Nebivolol: a review Expert Opin Pharmacother 5 893-9

[7] Samuelsson O(2004)Pharmacological mechanisms of clinically favorable properties of a selective β Cardiovasc Drug Rev 22 155-68

[8] Lindholm LH(2004)-adrenoceptor antagonist, nebivolol Blood Press Suppl 13 17-32

[9] Lopez-Sendón J(1991)Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients J Cardiovasc Pharmacol 17 964-9

[10] Swedberg K(2001)Nebivolol induces endothelium-dependent relaxations of canine coronary arteries Br J Pharmacol 133 1330-8

[1] McNeely W(1999)Nebivolol in the management of essential hypertension: a review Drugs 57 633-51

[2] Goa KL(2005)Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis Lancet 366 1545-53

[3] Lindholm LH(2004)Atenolol in hypertension: is it a wise choice? Lancet 364 1684-9

[4] Carlberg B(2004)Expert consensus document on β-adrenergic receptor blockers The task force on beta-blockers of the European Society of Cardiology. Eur Heart J 25 1341-62

[5] Samuelsson O(1992)Pharmacology of nebivolol J Pharm Belg 47 323-7

[6] Carlberg B(2004)Nebivolol: a review Expert Opin Pharmacother 5 893-9

[7] Samuelsson O(2004)Pharmacological mechanisms of clinically favorable properties of a selective β Cardiovasc Drug Rev 22 155-68

[8] Lindholm LH(2004)-adrenoceptor antagonist, nebivolol Blood Press Suppl 13 17-32

[9] Lopez-Sendón J(1991)Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients J Cardiovasc Pharmacol 17 964-9

[10] Swedberg K(2001)Nebivolol induces endothelium-dependent relaxations of canine coronary arteries Br J Pharmacol 133 1330-8